<DOC>
	<DOCNO>NCT01157572</DOCNO>
	<brief_summary>The primary objective study evaluate effect beta-blocker leave ventricular ( LV ) remodel asymptomatic patient moderate severe aortic regurgitation .</brief_summary>
	<brief_title>Effect Beta Blockade Left Ventricular Remodeling Function Moderate Severe Asymptomatic Aortic Regurgitation</brief_title>
	<detailed_description>The left ventricle responds volume load chronic aortic regurgitation ( AR ) series compensatory mechanism , include increase end-diastolic volume , increase chamber compliance accommodates increase volume without increase filling pressure , combination eccentric concentric hypertrophy . The great diastolic volume permit ventricle eject large total stroke volume maintain forward stroke volume normal range . This accomplished rearrangement myocardial fiber addition new sarcomere development eccentric LV hypertrophy . As consequence leave ventricular ejection fraction remain normal range . The clinical course chronic aortic regurgitation characterize prolonged phase stability leave ventricle adapts volume overload . Eventually myocardial failure ensue series complex event include change myocyte phenotype due re-expression fetal gene , cellular apoptosis alteration expression function contractile protein change extracellular matrix . The role long-term vasodilator therapy care asymptomatic patient severe aortic regurgitation controversial . Vasodilator therapy use reduce regurgitant volume , afterload , leave ventricular volume , wall stress effort preserve leave ventricular function reduce leave ventricular mass . Thus time surgical intervention find delayed calcium antagonist , ACE-inhibitors hydralazine , recent study find effect nifedipine enalapril time surgery leave ventricular volume function . The decision recommend operative intervention asymptomatic patient chronic , severe aortic regurgitation ( AR ) difficult aortic valve replacement ( AVR ) continue entail immediate risk , biologic mechanical valve still problem result significant morbidity mortality . On hand , mortality rate asymptomatic patient AR low , surgery improve quality life . Thus , indication asymptomatic patient must delay change occur predict increase risk operative long-term death AVR . At present indication aortic valve replacement development symptom , increase leave ventricular volume decline leave ventricular function .</detailed_description>
	<mesh_term>Ventricular Remodeling</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Moderate severe aortic valve insufficiency Asymptomatic Arrhythmia Other severe valve disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Aortic valve insufficiency</keyword>
	<keyword>Beta-blocker</keyword>
</DOC>